...
首页> 外文期刊>Nephron >CD44-Positive Glomerular Parietal Epithelial Cells in a Mouse Model of Calcineurin Inhibitors-Induced Nephrotoxicity
【24h】

CD44-Positive Glomerular Parietal Epithelial Cells in a Mouse Model of Calcineurin Inhibitors-Induced Nephrotoxicity

机译:CAD44阳性肾小球凝血性上皮细胞在钙蛋白抑制剂诱导的肾毒性诱导的肾毒性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background/Aims: Calcineurin inhibitors (CNIs) such as cyclosporine A (CsA) and tacrolimus are immunosuppressants that are frequently used as "key drugs" in the fields of transplantation, steroid resistance, refractory nephrotic syndrome, and autoimmune disease. However, long-term CNI use causes nephrotoxicity, the features of which are arterio-lar hyalinosis, tubular atrophy, striped interstitial fibrosis, and focal segmental glomerulosclerosis (FSGS). We investigated whether FSGS in CNI-induced nephrotoxicity is associated with CD44-positive glomerular parietal epithelial cells (PECs), which play a significant role in experimental and human FSGS pathogenesis. Methods: We utilized the mouse model of CsA-induced nephrotoxicity, as well as controls. Histopathological and functional data were sequentially collected from 1 to 25 weeks after CsA injection. Glomerular expression of CD44 was immunohistochemically evaluated, as were markers for glomerular podocytes and PECs. Results: Glomerular CD44 expression occurred from 2 weeks after CsA injection and gradually increased in the CsA group. CD44-positive glomerular cells showed coexpression of claudin-1 (PEC marker) but not of synaptopodin (podocyte marker). From 20 weeks after CsA injection, the cells formed a bridge between Bowman's capsule and the capillary tuft. These features are compatible with those of activated PECs, in which increased foot process effacement leads to bridge formation, and subsequently to an increase in glomerulosclerosis and a decrease in the expression of podocyte markers from 20 weeks. Conclusion: CD44-positive (activated) PECs reflect extremely early podocyte injury in the progression of FSGS formation and may be a good marker for early detection of CNI-induced nephrotoxicity.
机译:摘要背景/目的:Carchineurin抑制剂(CNI)如环孢菌素A(CSA)和Tacrolimus是免疫抑制剂,其通常用作移植,类固醇抗性,难治性肾病综合征和自身免疫疾病领域的“关键药物”。然而,长期CNI使用导致肾毒性,其特征是动脉透明度,管状萎缩,条纹间质纤维化和局灶性节段性肾小球粥样硬化(FSG)。我们调查了CNI诱导的肾毒性的FSGs是否与CD44阳性肾小球间上皮细胞(PEC)相关,这在实验和人体FSGS发病机制中起着重要作用。方法:我们利用CSA诱导的肾毒性的小鼠模型,以及对照。 CSA注射后1至25周顺序地收集组织病理学和功能数据。 CD44的肾小球表达是免疫组织化学评价的,与肾小球哆级和PECs的标志物。结果:CSA注射后2周发生肾小球CD44表达,逐渐增加CSA组。 CD44阳性肾小球细胞显示CLAUDIN-1(PEC标志物)的共表达,但不具有SENAPTOPODIN(Podocyte标志物)。从CSA注射后20周,细胞在Bowman的胶囊和毛细血管簇之间形成了一座桥梁。这些特征与激活的PECs兼容,其中脚踏工艺效应增加导致桥梁形成,随后从20周改为肾小球粥样硬化的增加和阴键标记表达的减少。结论:CD44阳性(活化的)PECs在FSGS形成的进展中反映了极早的泛细胞损伤,可能是早期检测CNI诱导的肾毒性的良好标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号